This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: University of Pittsburgh, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,960 
1 out of 958 
Years Active: 2022-2023
Title: Yolandi Van der Merwe: Innovator in Ocular Delivery Systems
Introduction
Yolandi Van der Merwe is a prominent inventor based in Pittsburgh, PA, who has made significant contributions to the field of ocular medicine. With two patents under her name, her innovative work focuses on improving retinal health and the local delivery of therapeutic agents.
Latest Patents
One of Van der Merwe's latest patents is titled "Ocular Applications of Matrix Bound Vesicles (MBVs)." This patent discloses methods aimed at increasing retinal ganglion cell survival in individuals requiring intervention. The methods entail selecting a subject in need and administering a therapeutically effective amount of isolated nanovesicles derived from an extracellular matrix, hence promoting cell survival.
Additionally, she holds a patent for "Devices and Methods for Local Delivery of Tacrolimus." This invention comprises devices designed for the localized delivery of tacrolimus or its derivatives. Through a polymeric matrix, these devices enable delayed and extended release, specifically targeting injured nervous system tissue upon implantation. This innovative approach paves the way for more effective therapeutic strategies in treating nervous system injuries.
Career Highlights
Van der Merwe has extensive experience collaborating with esteemed institutions, including the University of Pittsburgh and the Department of Veterans Affairs, representing the United States. Her role in these organizations has enabled her to advance her research and contribute to the development of cutting-edge medical technologies.
Collaborations
Throughout her career, Yolandi has worked alongside notable colleagues, including Michael Brandt Steketee and Kia M. Washington. These collaborations reflect her commitment to fostering innovation through teamwork and shared expertise in the field.
Conclusion
Yolandi Van der Merwe is a trailblazer in the realm of ocular therapy innovations. Her patented methods and devices demonstrate her dedication to enhancing patient outcomes through targeted medical treatments. As a driving force in her field, Van der Merwe continues to inspire future advancements in ocular medicine and the delivery of therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile